Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$915,954
+$608,553 QoQ
Shares Held
323,659
+122.2% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 136 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Derivatives in NKTX
reported options exposure · as of Sep 30, 2024CallValue
$298,772
CallShares
66,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. NKTX ranks #252 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NKTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $915,954 | 323,659 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $307,401 | 145,688 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $193,606 | 104,652 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,549,382 | 748,494 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,109,597 | 603,042 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,494,353 | 600,142 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $298,772 | 66,100 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $1,065,477 | 235,725 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,664,711 | 281,677 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $393,765 | 36,426 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $698,735 | 105,869 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,685 | 14,162 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $30,535 | 13,943 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $49,703 | 14,001 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,040,325 | 173,677 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $601,741 | 45,725 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $492,800 | 40,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $722,630 | 63,500 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $153,630 | 13,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,677,408 | 174,424 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,451,697 | 231,992 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $556,200 | 20,000 | Put | Sole | 2021-11-15 | |
| 2021-06-30 | $10,777,198 | 340,082 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,936,499 | 241,231 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $782,021 | 12,722 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||